21 related articles for article (PubMed ID: 19010744)
1. Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate.
Jin LH; Kim BH; Lee JH; Lee K; Kwack K; Yim SV
Transl Clin Pharmacol; 2017 Dec; 25(4):166-172. PubMed ID: 32095470
[TBL] [Abstract][Full Text] [Related]
2. Modeling population pharmacokinetics of morniflumate in healthy Korean men: extending pharmacometrics analysis to niflumic acid, its major active metabolite.
Jeong SH; Jang JH; Lee YB
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):843-856. PubMed ID: 37515737
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Determination of Cysteamine and Cystamine in Cosmetics by Ion-Pairing Reversed-Phase High-Performance Liquid Chromatography.
Kim Y; Na DH
Toxicol Res; 2019 Apr; 35(2):161-165. PubMed ID: 31015898
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of niflumic acid in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection and its application to a bioequivalence study of talniflumate tablets.
Lee HW; Won KJ; Cho SH; Ha YH; Park WS; Yim HT; Baek M; Rew JH; Yoon SH; Yim SV; Chung JH; Lee KT
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(2):215-20. PubMed ID: 15921965
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography.
Jang DJ; Park JS; Ko HR; Jee JP; Kim JK; Kim ST; Kim CK
Biomed Chromatogr; 2005 Jan; 19(1):32-5. PubMed ID: 15470687
[TBL] [Abstract][Full Text] [Related]
6. Determination of talniflumate and niflumic acid in human plasma by liquid chromatography-tandem mass spectrometry.
Kang W; Kim K
Anal Sci; 2009 Apr; 25(4):571-4. PubMed ID: 19359802
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of tetrahydropalmatine, protopine, and palmatine in rat plasma by LC-ESI-MS and its application to a pharmacokinetic study.
Ma H; Wang Y; Guo T; He Z; Chang X; Pu X
J Pharm Biomed Anal; 2009 Feb; 49(2):440-6. PubMed ID: 19121909
[TBL] [Abstract][Full Text] [Related]
8. Determination of ipriflavone in human plasma by LC-MS and its application in a pharmacokinetic study.
Yun C; Ding L; Leng Y; Zhu H; Wen A; Yang L
Biomed Chromatogr; 2012 Jan; 26(1):123-8. PubMed ID: 21594876
[TBL] [Abstract][Full Text] [Related]
9. Chromatographic and mass spectrometric methods for quantitative determination of 3-nitrotyrosine in biological samples and their application to human samples.
Ryberg H; Caidahl K
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):160-71. PubMed ID: 17344105
[TBL] [Abstract][Full Text] [Related]
10. Talniflumate (Genaera).
Knight D
Curr Opin Investig Drugs; 2004 May; 5(5):557-62. PubMed ID: 15202731
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-mass spectrometric method for the sensitive determination of niflumic acid in human plasma and its application to pharmacokinetic study of talniflumate tablet.
Park EJ; Na DH; Shin YH; Lee KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):159-62. PubMed ID: 19010744
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
